PARIS, Oct. 7, 2025 /PRNewswire/ -- With Frieze London about to kick off, followed by Art Basel Paris, Artprice News®…
SUNNYVALE, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the safety-certified communication framework leader for SDVs, today announced…
Celebrating culture, community, and impact through a two-day flagship event focused on belonging and innovation MUMBAI, India, Oct. 7, 2025…
OTTAWA, ON, Sept. 30, 2025 /PRNewswire/ -- Solace, the leader in powering real-time, event-driven integration for the Agentic AI world, today…
TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage…
2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…
September 18, 2025 16:30 ET | Source: NovaBay Pharmaceuticals Inc. EMERYVILLE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals,…